Literature DB >> 7052485

Dynorphin-related immunoreactive peptides in rat brain and pituitary.

V Höllt, I Haarmann, K Bovermann, M Jerlicz, A Herz.   

Abstract

Antisera recognizing dynorphin 1-13, but not other opioid peptides with a high avidity, have been generated in rabbits. Using a radioimmunoassay technique levels of dynorphin-immunoreactivity (dyn-ir) have been measured in the brain and pituitary of rats. The concentrations of dyn-ir ranged from a maximum in the intermediate/posterior lobe of the pituitary (about 1200 pmol/g) to a minimum in the cerebellum (about 1 pmol/g) as follows: pituitary intermediate/posterior lobe greater than adenohypophysis greater than hypothalamus greater than hippocampus = striatum = midbrain = thalamus = medulla/pons greater than cortex greater than cerebellum. Gel-filtration of hypothalamic extracts revealed 4 immunoreactive components with apparent molecular weights (MW) of 3500, 2400, 1300 and less than 1000 daltons, respectively. No dyn-ir was found to elute as dynorphin1-13 (MW = 1700). The 2400 and 1300 dalton materials showed opiate-like activity on the guinea-pig ileum longitudinal muscle preparation, indicating that a substantial part of the dyn-ir measured represented biologically active material.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7052485     DOI: 10.1016/0304-3940(80)90318-3

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  17 in total

Review 1.  30 years of dynorphins--new insights on their functions in neuropsychiatric diseases.

Authors:  Christoph Schwarzer
Journal:  Pharmacol Ther       Date:  2009-05-28       Impact factor: 12.310

2.  WIN 44,441: A Stereospecific and Long-Acting Narcotic Antagonist.

Authors:  P L Wood; C Pilapil; M Thakur; J W Richard
Journal:  Pharm Res       Date:  1984-01       Impact factor: 4.200

3.  Electrical stimulation in vivo increases the expression of proenkephalin mRNA and decreases the expression of prodynorphin mRNA in rat hippocampal granule cells.

Authors:  B J Morris; K J Feasey; G ten Bruggencate; A Herz; V Höllt
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

4.  Intracerebral injection of different antibodies against endogenous opioids suggests alpha-neoendorphin participation in control of feeding behaviour.

Authors:  R Schulz; A Wilhelm; G Dirlich
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-06       Impact factor: 3.000

5.  Pro-dynorphin peptides are found in the same neurons throughout rat brain: immunocytochemical study.

Authors:  S J Watson; H Khachaturian; L Taylor; W Fischli; A Goldstein; H Akil
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

6.  A dynorphin-like opioid in the central nervous system of an amphibian.

Authors:  R I Cone; A Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

7.  Rimorphin, a unique, naturally occurring [Leu]enkephalin-containing peptide found in association with dynorphin and alpha-neo-endorphin.

Authors:  D L Kilpatrick; A Wahlstrom; H W Lahm; R Blacher; S Udenfriend
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

8.  Immunoreactive dynorphin in mammalian spinal cord and dorsal root ganglia.

Authors:  L J Botticelli; B M Cox; A Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

9.  Generalization tests with intraventricularly applied pro-enkephalin B-derived peptides in rats trained to discriminate the opioid kappa receptor agonist ethylketocyclazocine.

Authors:  G T Shearman; R Schulz; P W Schiller; A Herz
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

10.  Dynorphin-containing axons directly innervate noradrenergic neurons in the rat nucleus locus coeruleus.

Authors:  B A S Reyes; A D Johnson; J D Glaser; K G Commons; E J Van Bockstaele
Journal:  Neuroscience       Date:  2007-02-07       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.